Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Levels in Newborns After Maternal Episiotomy
NL-OMON21641Active, not recruiting
- Sponsor
- Amphia Ziekenhuis
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine, sponsored by Amphia Ziekenhuis. Primary endpoints: Lidocaine concentration in the newborn at delivery and Lidocaine concentration in the mother at delivery. Started Feb 2013; status: active, not recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NL-OMON21641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21641.